Progesterone Therapy–Associated Pruritus
Progesterone therapy can cause pruritus through localized reactions (such as injection-site symptoms) and through progesterone hypersensitivity reactions. [1], [2]
Evidence Supporting Progesterone-Associated Pruritus
A case report described localized pruritus occurring after subdermal contraceptive implant exposure and noted monitoring for progesterone-implant–related complications. [1]
A prospective pharmacovigilance study of intramuscular progesterone microspheres assessed patient-reported pruritus as part of local tolerability monitoring. [2]
A study of female sex-hormone hypersensitivity in premenstrual syndrome reported hypersensitivity reactions to progesterone in patients with sex-hormone–associated skin disease that included pruritus vulvae. [3]
Mechanisms of Progesterone-Induced Itch
Progesterone can trigger delayed hypersensitivity reactions in some patients with sex-hormone–related skin disease. [3]
Progesterone administration can also produce local intolerance symptoms that may include pruritus when evaluated as an adverse effect. [2]
Clinical Presentations
Progesterone-associated pruritus may present as localized pruritus after exposure to progesterone-containing contraceptive devices. [1]
Progesterone-associated pruritus may present as vulvar itching in the setting of progesterone hypersensitivity in patients with recurrent hormone-associated skin symptoms. [3]
Management Considerations
Progesterone-associated pruritus warrants evaluation for hypersensitivity when symptoms correlate with progesterone exposure and recur. [3]
Progesterone-associated pruritus warrants assessment of exposure route and timing to determine whether symptoms are likely local (injection-site or device-associated) or systemic. [1], [2]
When Progesterone Therapy Should Be Reassessed
Progesterone-containing contraceptive device therapy should be reassessed when pruritus develops shortly after insertion or implantation and other causes are not identified. [1]
Progesterone therapy should be reassessed when pruritus is accompanied by features consistent with hypersensitivity reactions to female sex hormones. [3]
Key Drug- and Formulation-Related Nuances
Progesterone-associated pruritus has been described in association with progesterone implants and intramuscular progesterone formulations that were systematically evaluated for local tolerability symptoms. [1], [2]
Progesterone hypersensitivity can manifest as hormone-associated vulvar pruritus in patients evaluated for progesterone-related skin hypersensitivity. [3]
Reporting and Documentation
Adverse event documentation should include timing of onset relative to progesterone exposure and anatomic distribution of itching to support causality assessment. [1], [2]